| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Acknowledgments
|
|
|
|
25 |
S1 |
p. xii
|
article
|
| 2 |
Adoption of Multi-Gene Assays in HR +, HER2– Breast Cancer (BC) Patients in Europe: Results of the Multidisciplinary Application of Genomics in Clinical Practice (MAGIC) Survey
|
Aapro, M.S.
|
|
|
25 |
S1 |
p. i5
|
article
|
| 3 |
Agreement Between Predicted Response by Imaging Methods and Pathological Response by RCB in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
|
Schermann, C.
|
|
|
25 |
S1 |
p. i19
|
article
|
| 4 |
Alternate Epigenetic Mechanism for the Repression of BRCA1 in Sporadic Breast Cancers Mediated by MIR182
|
Korlimarla, A.
|
|
|
25 |
S1 |
p. i8
|
article
|
| 5 |
A Meta-Analysis of Oestrogen Receptor, Progesterone Receptor and Human Epidermal Growth Factor Receptor 2 Discordance Between Primary Breast Cancer and Metastases
|
Aurilio, G.
|
|
|
25 |
S1 |
p. i8
|
article
|
| 6 |
Analysis of Molecular Scores for the Prediction of Distant Recurrence According to Body Mass Index and Age at Baseline
|
Sestak, I.
|
|
|
25 |
S1 |
p. i8
|
article
|
| 7 |
Androgen Receptor Expression in a Population-Based Prospective Breast Cancer Cohort
|
Elebro, K.
|
|
|
25 |
S1 |
p. i18
|
article
|
| 8 |
A Negative Progesterone Receptor in Luminal Her-2 Negative Breast Cancer by Age at Diagnosis: 10 Years Follow-Up
|
Olbrecht, S.
|
|
|
25 |
S1 |
p. i8
|
article
|
| 9 |
A Novel Methylation Signature that Reflects Intratumoral Lymphocyte Infiltration in Breast Cancer and Predicts for Response to Anthracycline Treatment
|
Jeschke, J.
|
|
|
25 |
S1 |
p. i8
|
article
|
| 10 |
A Phase 1 Open-Label Fixed-Sequence Two-Period Crossover Study of the Effect of Multiple Doses of Tamoxifen on Palbociclib (PD-0332991) Pharmacokinetics in Healthy Male Volunteers
|
Hoffman, J.T.
|
|
|
25 |
S1 |
p. i25
|
article
|
| 11 |
A Phase 1 Open-Label Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Enzalutamide Alone or Combined with an Aromatase Inhibitor in Women with Advanced Breast Cancer
|
Traina, T.A.
|
|
|
25 |
S1 |
p. i4
|
article
|
| 12 |
A Powerful Drug-Delivery System in Reducing Cardio-Toxicity of Trastuzumab: A Bio-Distribution Study Using 99TC Radiolabeling Technique
|
Khanna, A.
|
|
|
25 |
S1 |
p. i25
|
article
|
| 13 |
Association of Symptoms and Breast Cancer in Population Screening for Cancer
|
Singh, D.
|
|
|
25 |
S1 |
p. i1
|
article
|
| 14 |
Author Index
|
|
|
|
25 |
S1 |
p. i28-i30
|
article
|
| 15 |
Axillary Sentinel Lymph Node Biopsy: Is it Indicated in Patients with Microinvasive Breast Cancer?
|
Ko, B.
|
|
|
25 |
S1 |
p. i3
|
article
|
| 16 |
Biomarkers and Molecular Subtypes in Primary Breast Tumors and Metastases: Associations with Liver Metastases and Outcome
|
Kimbung, S.
|
|
|
25 |
S1 |
p. i8
|
article
|
| 17 |
Breast International Group (BIG)
|
|
|
|
25 |
S1 |
p. v
|
article
|
| 18 |
CD146 Suppresses Breast Tumor Invasion via its Novel Downstream Transcriptional Target Gene, TIMPV
|
Ouhtit, A.
|
|
|
25 |
S1 |
p. i23
|
article
|
| 19 |
Characterization of B Cells Infiltrating Human Breast Cancer
|
Garaud, S.
|
|
|
25 |
S1 |
p. i17
|
article
|
| 20 |
Characterization of Tumor Infiltrating Lymphocytes in Human Breast Cancer by Infrared Imaging
|
Verdonck, M.
|
|
|
25 |
S1 |
p. i19
|
article
|
| 21 |
Codelivery of E2F3 Sirna and Doxorubicin By Zinc Oxide Nanorods (ZnONRs) Promoted Breast Tumor Suppression
|
Vimala, K.
|
|
|
25 |
S1 |
p. i25
|
article
|
| 22 |
Comparison of the Indocyanine Green Dye Method Versus the Combined Method of Indigo Carmine Blue Dye with Indocyanine Green Fluorescence Imaging for Sentinel Lymph Node Biopsy in Patients with Stage I Or II Breast Cancer
|
Takemoto, N.
|
|
|
25 |
S1 |
p. i3
|
article
|
| 23 |
CRP and Granulocyte-to-Lymphocyte Ratio as Predictors of Breast Cancer Death in American Non-Institutionalized Women
|
Wulaningsih, W.
|
|
|
25 |
S1 |
p. i8
|
article
|
| 24 |
CXCL13-Producing Follicular Helper T Cells in Human Breast Cancer
|
Gu-Trantien, C.
|
|
|
25 |
S1 |
p. i17
|
article
|
| 25 |
Detection of Breast Cancer and Abnormal Mammograms with a Rapid Point-of-Care Breath Test
|
Phillips, M.
|
|
|
25 |
S1 |
p. i1
|
article
|
| 26 |
Development of a BRCA1-Like Signature in Triple Negative Breast Cancers Within the Rather (Rational Therapy for Breast Cancer) Consortium
|
Simon, I.M.
|
|
|
25 |
S1 |
p. i8
|
article
|
| 27 |
DFNA5 Methylation: A Potential Biomarker for Breast Cancer?
|
Croes, L.
|
|
|
25 |
S1 |
p. i18
|
article
|
| 28 |
Different Tumor Biology in Russian and Dutch Patients with Breast Cancer Stage I
|
Kolyadina, I.V.
|
|
|
25 |
S1 |
p. i18
|
article
|
| 29 |
Discordance Between Unbound Paclitaxel Plasma Levels and Efficacy—Lessons From Tocosol-Paclitaxel
|
Motamed, K.
|
|
|
25 |
S1 |
p. i25
|
article
|
| 30 |
Drugging the Undruggables - Cell-Permeable Peptide Inhibitors of the WNT Signaling Pathway in Breast Cancer
|
Arndt, V.
|
|
|
25 |
S1 |
p. i25
|
article
|
| 31 |
Drug Index
|
|
|
|
25 |
S1 |
p. i33
|
article
|
| 32 |
Editorial Board
|
|
|
|
25 |
S1 |
p. i-ii
|
article
|
| 33 |
Efficacy of Fulvestrant According to Duration and Type of Adjuvant Endocrine Treatment, in Metastatic Breast Cancer Patients Enrolled in the Confirm Trial
|
Malorni, L.
|
|
|
25 |
S1 |
p. i8
|
article
|
| 34 |
EIF4B as a Novel Target in EGFR Expressing Triple Negative Breast Cancer
|
Madden, J.M.
|
|
|
25 |
S1 |
p. i21
|
article
|
| 35 |
Europa Donna
|
|
|
|
25 |
S1 |
p. viii
|
article
|
| 36 |
Evaluation of Soluble E-Cadherin as a Predictive Marker for Response to Preoperative Systemic Chemotherapy in Early Breast Cancer
|
Suppan, C.
|
|
|
25 |
S1 |
p. i18
|
article
|
| 37 |
Evolutionary Patterns of Microrna Expression Through the Course of Disease and Therapy in Recurrent Breast Cancer
|
Dadiani, M.
|
|
|
25 |
S1 |
p. i5
|
article
|
| 38 |
Fatty Acid Composition of Tissue Cultured Breast Carcinoma: Effect of Stearoyl-Coa Desaturase-1 (SCD-1) Inhibitor
|
Darabi, M.
|
|
|
25 |
S1 |
p. i21
|
article
|
| 39 |
Foundation “St.Gallen Oncology Conferences” (SONK)
|
|
|
|
25 |
S1 |
p. x
|
article
|
| 40 |
Gene Expression Analysis of Triple Negative Recurrent Lymphangitic Breast Cancer in Patients Receiving Antiangiogenic Therapy
|
Gelao, L.
|
|
|
25 |
S1 |
p. i18
|
article
|
| 41 |
Gene Expression of ESR1, PGR and HER2 in Lymph Node Homogenates and Concordance with IHC in Primary Breast Tumours
|
Haynes, B.P.
|
|
|
25 |
S1 |
p. i8
|
article
|
| 42 |
Generation of Mouse Models for the Identification of New Driver Pathways of Drug Resistance in Human Breast Cancer (BC)
|
Criscitiello, C.
|
|
|
25 |
S1 |
p. i23
|
article
|
| 43 |
Genetic Polymorphisms of MTHFR and GSTP1 is Associated with Chemotherapy Related Toxicity in Breast Cancer Patients
|
Svergun, N.M.
|
|
|
25 |
S1 |
p. i18
|
article
|
| 44 |
Her 2 3+ Locally Advanced Breast Cancer and Brain Metastases
|
Tomasevic, Z.I.
|
|
|
25 |
S1 |
p. i8
|
article
|
| 45 |
IG-001—A Non-Biologic Micellar Paclitaxel Formulation for the Treatment of Metastatic Breast Cancer
|
Hwang, L.
|
|
|
25 |
S1 |
p. i25
|
article
|
| 46 |
Impakt 2014 Officers
|
|
|
|
25 |
S1 |
p. xi
|
article
|
| 47 |
Iron (De)Regulation in Breast Cancer: a Role for Stromal Inflammatory Cells in the Tumor Microenvironment
|
Marques, O.
|
|
|
25 |
S1 |
p. i17
|
article
|
| 48 |
Low Expression of FGD3, a Putative Guanine Nucleotide Exchange Factor for CDC42, is Prognostic of Poor Outcome in Breast Cancer
|
Willis, S.
|
|
|
25 |
S1 |
p. i18
|
article
|
| 49 |
Lymphocytes Infiltrating Breast Cancer : Density, Composition and Organization
|
Buisseret, L.
|
|
|
25 |
S1 |
p. i17
|
article
|
| 50 |
Mechanism of Action for Combined CDK4/6 and Er Inhibition in ER Positive Breast Cancer
|
Koehler, M.
|
|
|
25 |
S1 |
p. i21
|
article
|
| 51 |
Metastatic Breast Cancer: Getting the Facts from Peripheral Blood
|
Salamoon, M.
|
|
|
25 |
S1 |
p. i21
|
article
|
| 52 |
Methylation of DNA Free in Blood Sample as Prognostic Factor in Breast Cancer Subtype
|
Martinez-Galan, J.
|
|
|
25 |
S1 |
p. i18
|
article
|
| 53 |
MIR-18A and MIR-18B Expression in Erα Negative Breast Cancers by Chromogenic in Situ Hybridization (CISH)
|
Jonsdottir, K.
|
|
|
25 |
S1 |
p. i18
|
article
|
| 54 |
Molecular Changes in Lobular Breast Cancers in Response to Neoadjuvant Letrozole
|
Arthur, L.
|
|
|
25 |
S1 |
p. i5
|
article
|
| 55 |
Molecular Subtype of Breast Cancer Metastases Significantly Influences Patient Post-Relapse Survival
|
Tobin, N.P.
|
|
|
25 |
S1 |
p. i5
|
article
|
| 56 |
Mutation Analysis for BRIP1 in Korean Patients with BRCA1/2 Mutations-Negative High-Risk Breast Cancer
|
Kim, H.
|
|
|
25 |
S1 |
p. i5
|
article
|
| 57 |
Next-Generation Sequencing of Epigenetically Silenced Genes in Brcax Cases and Ancestry Matched Controls
|
Aloraifi, F.
|
|
|
25 |
S1 |
p. i5
|
article
|
| 58 |
OPG and PGR Show Similar Cohort Specific Effects as Prognostic Factors in ER Positive Breast Cancer
|
Karn, T.
|
|
|
25 |
S1 |
p. i5
|
article
|
| 59 |
Optimal Duration of Cardiac Monitoring in Metastatic HER2 Positive Breast Cancer Patients Receiving Trastuzumab
|
Chiu, K.
|
|
|
25 |
S1 |
p. i4
|
article
|
| 60 |
Overexpression of G Protein-Activated Inward Rectifier Potassium Channel 1 (GIRK1) is Associated with Lymph Node Metastasis and Poor Prognosis in Breast Cancer
|
Kammerer, S.
|
|
|
25 |
S1 |
p. i18
|
article
|
| 61 |
Patterns of Failure in Pathologic N1 Breast Cancer Patients Treated with Mastectomy and Radiotherapy
|
Mehmood, T.
|
|
|
25 |
S1 |
p. i3
|
article
|
| 62 |
PET/CT Imaging of 64CU-Labelled HER2 Liposomal Doxorubicin (64CU-MM-302) Quantifies Variability of Liposomal Drug Delivery to Diverse Tumor Lesions in HER2-Positive Breast Cancer Patients
|
Hendriks, B.
|
|
|
25 |
S1 |
p. i19
|
article
|
| 63 |
Phase I/IIA Study with CNS-Targeted Liposomal Doxorubicin (2B3-101) in Patients with Brain Metastases (BM) From Breast Cancer (BC) and Other Brain Tumors
|
Aftimos, P.G.
|
|
|
25 |
S1 |
p. i25
|
article
|
| 64 |
PKCα Crosstalk with GSTP1 and BCL2 Mediates Therapeutic Response in Breast Cancer
|
Singh, S.
|
|
|
25 |
S1 |
p. i21
|
article
|
| 65 |
Prognostic Impact of Disseminated Tumor Cell in Breast Cancer Patients: 10 Year Follow Up Results
|
Kim, K.S.
|
|
|
25 |
S1 |
p. i8
|
article
|
| 66 |
Prognostic Outcomes of Concurrent GNRH Agonist Use with Chemotherapy
|
Bae, S.Y.
|
|
|
25 |
S1 |
p. i2
|
article
|
| 67 |
Prognostic Role of Luminal Subtype in Metastatic Breast Cancer Patients Treated with Fulvestrant in the Confirm Trial
|
Migliaccio, I.
|
|
|
25 |
S1 |
p. i8
|
article
|
| 68 |
Reproducibility of Assessing Immune Infiltration in Core Biopsies Compared to Primary Breast Tumors
|
Wang, X.
|
|
|
25 |
S1 |
p. i17
|
article
|
| 69 |
Role of Magnetic Resonance Imaging in Non-Palpable Breast Cancer to Diagnose Breast Cancer with Stereo-Guided Biopsy
|
Takayanagi, H.
|
|
|
25 |
S1 |
p. i1
|
article
|
| 70 |
Safety and Efficacy of MK-8669 (Ridaforolimus) + MK-2206 (AKT Inhibitor) in Patients with Advanced Breast Cancer with PI3K Pathway Dependence
|
Gupta, S.
|
|
|
25 |
S1 |
p. i25
|
article
|
| 71 |
Statin-Induced Anti-Proliferative Effects via Cyclin D1 and P27 in a Window-of-Opportunity Breast Cancer Trial
|
Feldt, M.
|
|
|
25 |
S1 |
p. i25
|
article
|
| 72 |
Stem Cell Like Phenotype in Inflammatory Breast Cancer
|
El Bastawisy, A.
|
|
|
25 |
S1 |
p. i8
|
article
|
| 73 |
Stromal Characteristics are Potential Prognostic Markers for Ipsilateral Locoregional Recurrence in Ductal Carcinoma in Situ (DCIS)
|
Van Bockstal, M.
|
|
|
25 |
S1 |
p. i8
|
article
|
| 74 |
Subject Index
|
|
|
|
25 |
S1 |
p. i31-i32
|
article
|
| 75 |
Table of Contents
|
|
|
|
25 |
S1 |
p. iv
|
article
|
| 76 |
Targeting CDK4/6 in Her2 Positive Breast Cancer: Therapeutic Effect, Markers, and Combination Strategies
|
Knudsen, E.
|
|
|
25 |
S1 |
p. i21
|
article
|
| 77 |
Targeting ER Stress by the Combination of Proteasome Inhibitors and HIV Protease Inhibitors in Preclinical Models of Triple-Negative Breast Cancer
|
Marsico, J. Gibbons
|
|
|
25 |
S1 |
p. i25
|
article
|
| 78 |
TGF-β2, a Novel Target of CD44-Promoted Breast Cancer Invasion
|
Al-Riyami, H.
|
|
|
25 |
S1 |
p. i23
|
article
|
| 79 |
The BRCA Cancer Gene as a Useful Predictor for Double Primary Breast and Ovarian Cancer: a Meta-Analysis
|
Sattaratnamai, A.
|
|
|
25 |
S1 |
p. i5
|
article
|
| 80 |
The Clinical Impact of Using the IHC4 Score: Our MDT Experience in a Prospective Series of Postmenopausal Women with ER Positive Early Breast Cancer
|
Yeo, B.J.
|
|
|
25 |
S1 |
p. i2
|
article
|
| 81 |
The European Organisation for Research and Treatment of Cancer (EORTC)
|
|
|
|
25 |
S1 |
p. vii
|
article
|
| 82 |
The European Society for Medical Oncology (ESMO)
|
|
|
|
25 |
S1 |
p. vi
|
article
|
| 83 |
The European Society of Breast Cancer Specialists (EUSOMA)
|
|
|
|
25 |
S1 |
p. ix
|
article
|
| 84 |
The High DSS1 Expression Involved in BRCA2 Stability is a Marker for Breast Cancer of Poor Prognosis
|
Rezano, A.
|
|
|
25 |
S1 |
p. i18
|
article
|
| 85 |
The Interplay Between the Cell Adhesion Molecules CD44 and CD146 in Breast Cancer Metastasis
|
Gupta, I.
|
|
|
25 |
S1 |
p. i23
|
article
|
| 86 |
The PATH Biobank: Re-Consenting Patients Regarding Genomic Research
|
Mayer, C.
|
|
|
25 |
S1 |
p. i18
|
article
|
| 87 |
The Prognosis of Signal Transducer and Activator of Transcription 3 Expression On Breast Cancer Survival: a Meta-Analysis and Retrospective Study
|
Mao, Y.
|
|
|
25 |
S1 |
p. i18
|
article
|
| 88 |
The Risk of Breast Cancer Among Women Who Start Smoking as Teenagers
|
Tagbarha, M.O.
|
|
|
25 |
S1 |
p. i1
|
article
|
| 89 |
Title Page
|
|
|
|
25 |
S1 |
p. iii
|
article
|
| 90 |
Translational Research Index
|
|
|
|
25 |
S1 |
p. i34
|
article
|
| 91 |
USP2 Promotes Progression in Triple Negative Breast Cancer
|
Qu, Q.
|
|
|
25 |
S1 |
p. i8
|
article
|
| 92 |
Validation of Electrical Impedance Tomography Qualitative and Quantitative Values, and Comparison of Numeric Pain Distress Score Against Mammography
|
Juliana, N.
|
|
|
25 |
S1 |
p. i19
|
article
|
| 93 |
WT1, NY-ESO-1 and Prame Expression in Breast Cancer Subtypes
|
Esposito, A.
|
|
|
25 |
S1 |
p. i17
|
article
|
Journal description